"COVID and Lung Cancer - How Experts in Cancer and Virology Joined Forces in a Challenging Time"
Mount Sinai experts in cancer and virology have joined forces in this challenging time. Researchers at the Icahn School of Medicine at Mount Sinai recently received a grant to establish a NCI/SeroNet Center for Serological Excellence at Mount Sinai with a focus on lung cancer. The Center will be led by Fred R. Hirsch, MD, PhD, executive director for the Center for Thoracic Oncology at Mount Sinai’s Tisch Cancer Institute and Adolfo Garcia-Sastre, PhD, an expert in virology at the Icahn School of Medicine at Mount Sinai. The multidisciplinary team of Mount Sinai researchers and clinicians can assist with SeroNet’s effort to rapidly deploy and expand SARS-CoV-2 serological testing capacity and practice in the community.
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Nov 04, 2022 View All Press Releases
Study Identifies New Gene That Drives Colon Cancer
Oct 14, 2022 View All Press Releases
Mount Sinai Receives Grant to Enhance Patient-Centric, Team-Based Pancreatic Cancer Care
Apr 19, 2022 View All Press Releases